Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Arthritis Ireland
Talk to us: 01 661 8188 / 0818 252 846
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Linkedin
Helpline Donate
  • Twitter
Menu
  • About us
    • Why we exist
    • News
    • Who we are
      • Our team
      • Our board
    • Finances
    • Strategic plan
    • Job opportunities
  • About arthritis
    • Conditions
    • Booklets
    • Medications
      • Biosimilars
    • Physical activity
    • Pregnancy and arthritis
    • Work and Arthritis
  • Get help
    • Covid-19 (coronavirus)
    • Newly diagnosed
    • Coping with Emotions
    • Get Support
      • Call our helpline
      • Peer-to-peer network
    • Volunteer
    • Complementary therapies
    • Healthcare team
    • Take Control with Exercise
    • Healthy eating
  • In your area
    • Our branches
    • Activites in your area
      • Clare
      • Cork
      • Donegal
      • Dublin
      • Galway
      • Kerry
      • Kildare
      • Kilkenny
      • Limerick
      • Longford
      • Louth
      • Mayo
      • Sligo
      • Waterford
      • Westmeath
      • Wexford
  • Support us
    • Donate
    • Fundraise
      • Get involved
      • Fundraising ideas and materials
      • Virtual fundraisers
      • Stories
      • Fundraisers
        • Create a fundraiser
    • Leave a legacy
    • Corporate partnerships
    • Become a Friend
  • Courses
    • Living Well with Arthritis Online
    • Living Well with Arthritis
    • Breaking the Pain Cycle
    • Be Active with Arthritis online
    • Be Active with Arthritis
    • Take Control with Exercise
  • Research
    • Covid-19 impact survey
    • Research we are funding
    • Arthritis Research Coalition Biobank
    • Research prioritisation exercise
    • Working on a cure
  • Shop
  • Admin
    • Log in
  • Basket: (0 items)

Biosimilars

A biosimilar medicine is a highly similar, but not identical, copy of an originator biologic medicine. A biosimilar contains a version of an active substance of a biologic medicine, which is referred to as the ‘reference medicine’ or ‘originator medicine’.

A biosimilar medicine is not an exact copy of its biologic counterpart because of the complex production process needed for these medicines. Like the reference medicine, a biosimilar medicine has a degree of natural variability, due to the biological nature of its ingredients.

However, when approved for use in people by the European Medicines Agency, any differences between a biosimilar and its reference medicine will have been shown not to affect safety or effectiveness.

This means that, in order to be licensed for use in people, a biosimilar medicine has to show that it is as safe and works as well as the originator medicine. All medicines, whether chemical or biological, have to be regulated for safety and approved before being made available to people.

While biosimilars have been used to treat cancer for many years, their use for people with inflammatory conditions like arthritis is relatively new in Ireland. However, this is changing as there is increasing availability of biosimilars for arthritis patients in Ireland.


Are biosimilar medicines the same as generic medicines?

No. Generics are small-molecule drugs made from synthesised chemicals that can be easily replicated, whereas biosimilars of advanced biologic medicines are much larger, complex molecules derived from living cells.

 

Biosimilars in Ireland

Since 2016 the HSE Medicines Management Programme (MMP) has supported the appropriate introduction of biosimilar medicines into clinical use in Ireland to enable safe and effective prescribing, while also promoting cost-effective initiatives.

In 2018, the MMP started a process to evaluate therapeutic areas where there is potential for biosimilar medicines to be introduced to allow for their safe, effective and cost-effective use. In deciding on the best value biologic (BVB), the MMP invited submissions from all relevant stakeholders including clinicians, professional bodies and the pharmaceutical industry to the process.

What this means is that when clinicians look to prescribe treatments for arthritis patients these will be considered to be the best value treatments. Overall by carrying out the BVB process and its implementation by clinicians, this will lead to significant savings for the health service.

Read the HSE information for patients about the best value biologics, January 2020. 

 

New patients

From 1 February 2020, it is HSE policy that adult patients who are commencing treatment with two particular drugs will be prescribed a BVB medicine. A new patient is an adult, who has never been prescribed these treatments before, or has not received these medicines within the last six months.

 

Existing patients

There is currently no change for existing patients. They will continue to receive their medicine under the high tech arrangement from their community pharmacy.

However, according to HSE policy, when existing patients present for a repeat prescription for those two biological medicines, the patient should be considered for switching to a BVB medicine. The decision to switch a patient to a biosimilar rests with the clinician; where it is clinically appropriate and after consultation with individual patients. Those that switch to a biosimilar are expected to have the same response as if they had stayed on the originator biologic.

 

How are biosimilars administrated?

Generally, biosimilars need to be given by infusion (intravenous or IV) in a hospital which may take several hours, or self-injected, using a needle and syringe or pen. This means, they are administered in exactly the same way as originator biologic therapies.

Published: 22nd October, 2019

Updated: 5th June, 2020

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Virtual Coffee Morning with Occupational Therapist Brid McOsker

    Virtual Coffee Morning with Occupational Therapist Brid McOsker

    Join us for a virtual coffee morning with guest speaker Brid McOsker, Occupational Therapist at Merlin Park Hospital in Galway. Brid has extensive experience in supporting people living with arthritis overcome daily challenges both large and small.

  • Support Not Giving Up

    Support Not Giving Up

  • Walk Where You Are - Virtual Walking Group

    Walk Where You Are - Virtual Walking Group

    Walk apart but in this together. Join our WhatsApp group for walkers to share progress and photos.

  • The management of arthritis symptoms with Ellen Forkan

    The management of arthritis symptoms with Ellen Forkan

    Our Galway Branch invite you to our virtual coffee morning to meet Ellen Forkan, a GMIT Sports & Exercise 4th year student doing her placement with our branch in Galway

Most read

  • Covid-19 (coronavirus)

    Covid-19 (coronavirus)

    Important information about Covid-19 (coronavirus) for people living with arthritis

  • Benefits of physical activity highlighted for people with arthritis – National Arthritis Week launched

    Benefits of physical activity highlighted for people with arthritis – National Arthritis Week launched

    National Arthritis Week launched today (20 April) with the theme "Every Movement Matters".

  • Awareness campaign about psoriatic arthritis launched

    Awareness campaign about psoriatic arthritis launched

    Sausage-like fingers or toes; a red scaly skin rash; pitted nails; and stiff, painful, swollen joints – these are some of the symptoms of psoriatic arthritis, which Arthritis Ireland is highlighting in a new health awareness campaign.

  • Survey highlights impact of Covid-19 on people with arthritis

    Survey highlights impact of Covid-19 on people with arthritis

    Research published by Arthritis Ireland to mark World Arthritis Day looks at the impact of Covid-19 on people living with arthritis.

  • Arthritis Ireland appoints new chairman

    Arthritis Ireland appoints new chairman

    Arthritis Ireland has announced the appointment of Tim O’Sullivan as its new chairman. He replaces Seoirse Smith who leaves the board after 10 years, including three as chair.

  • UCD arthritis research conference highlights importance of self-management

    UCD arthritis research conference highlights importance of self-management

    The third annual UCD arthritis research conference will take place online on 18 November

  • Awareness campaign launched to educate patients about new treatment options

    Awareness campaign launched to educate patients about new treatment options

    An information campaign to educate and inform patients about biosimilar medicines is launched today (3 March) by Arthritis Ireland.

  • Coping with emotions

    Coping with emotions

    When you have arthritis, you will also experience a range of different emotions. Here's some information about the types of emotions you might experience living with arthritis, how to deal with difficult emotions while living with arthritis, and the supports that are available for those experiencing difficult emotions.

  • Statement re cancellation of Arthritis Ireland events due to Covid-19

    Statement re cancellation of Arthritis Ireland events due to Covid-19

    Arthritis Ireland has cancelled all events for the foreseeable future, which is based on expert advice from the HSE.

  • Communications and digital marketing executive

    Communications and digital marketing executive

Tag cloud

#powerof10 appeal arthritis Arthritis Ireland christmas Corporate power of 10 Vhi Women's mini marathon virtual challenge

Latest tweet

Arthritis Ireland
1 Clanwilliam Square
Grand Canal Quay
Dublin 2
D02 DH77

Talk to us:
01 661 8188 / 0818 252 846

Helpline

  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Linkedin

RCN: 20011123; CHY: 6297; CRO: 78931

  • Contact us
  • Jobs
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

The development of this website was supported by the following companies, however, it was created without any input from them. The content and views expressed on the website are those of Arthritis Ireland, not of the sponsors.